We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+7.07%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$53.4B
AUM Growth
+$3.95B
(+8%)
Cap. Flow
+$662M
Cap. Flow
% of AUM
1.24%
Top 10 Holdings %
Top 10 Hldgs %
27.71%
Holding
4,164
New
242
Increased
1,490
Reduced
1,373
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$110M |
| 2 |
iShares Russell Mid-Cap ETF
IWR
|
+$101M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$95.7M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$78M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$54.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$28M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$25.9M |
| 3 |
US Bancorp
USB
|
+$25.2M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$24.6M |
| 5 |
SWCH
Switch, Inc. Class A Common Stock
SWCH
|
+$16.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.08% |
| 2 | Financials | 9.18% |
| 3 | Healthcare | 8.48% |
| 4 | Industrials | 7.72% |
| 5 | Consumer Staples | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Tandem Diabetes Care
TNDM
$1.22B
| $529K | ﹤0.01% |
5,427
+1,178
| +28% | +$105K |
|
1527
Canadian Imperial Bank of Commerce
CM
$109B
| $528K | ﹤0.01% |
9,272
-3,412
| -27% | -$187K |
|
1528
Oxford Industries
OXM
$613M
| $528K | ﹤0.01% |
5,337
-1,015
| -16% | -$95.3K |
|
1529
Alaska Air
ALK
$5.42B
| $527K | ﹤0.01% |
8,727
-209
| -2% | -$14.1K |
|
1530
Kforce
KFRC
$1.04B
| $527K | ﹤0.01% |
8,348
-707
| -8% | -$41.9K |
|
|
CUK
1531
DELISTED
Carnival PLC
CUK
| $526K | ﹤0.01% |
22,635
+2,311
| +11% | +$55.6K |
|
1532
iShares US Aerospace & Defense ETF
ITA
$14.5B
| $526K | ﹤0.01% |
4,803
+1,740
| +57% | +$187K |
|
|
INN
1533
Summit Hotel Properties
INN
$743M
| $525K | ﹤0.01% |
56,306
-169
| -0.3% | -$1.67K |
|
1534
TG Therapeutics
TGTX
$8.4B
| $525K | ﹤0.01% |
13,552
+88
| +0.7% | +$3.46K |
|
1535
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
$1.97B
| $525K | ﹤0.01% |
12,467
+11,876
| +2,009% | +$491K |
|
1536
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.68B
| $523K | ﹤0.01% |
29,274
| – | – |
|
1537
ENI
E
$72.9B
| $522K | ﹤0.01% |
21,420
+1,688
| +9% | +$42.1K |
|
1538
Ingevity
NGVT
$2.59B
| $522K | ﹤0.01% |
6,418
-1,610
| -20% | -$129K |
|
1539
Wayfair
W
$12.5B
| $522K | ﹤0.01% |
1,651
+100
| +6% | +$31.3K |
|
1540
SPX Corp
SPXC
$10.2B
| $518K | ﹤0.01% |
8,485
+368
| +5% | +$22.4K |
|
1541
Compass Diversified
CODI
$777M
| $517K | ﹤0.01% |
20,255
| – | – |
|
1542
Matador Resources
MTDR
$5.73B
| $517K | ﹤0.01% |
14,378
-6,793
| -32% | -$198K |
|
1543
East-West Bancorp
EWBC
$18B
| $516K | ﹤0.01% |
7,188
+13
| +0.2% | +$967 |
|
1544
Lufax Holding
LU
$1.33B
| $515K | ﹤0.01% |
11,419
+17
| +0.1% | +$857 |
|
1545
Radian Group
RDN
$5.22B
| $514K | ﹤0.01% |
23,070
-492
| -2% | -$11.5K |
|
1546
iShares Global REIT ETF
REET
$5.18B
| $512K | ﹤0.01% |
18,453
| – | – |
|
1547
PENN Entertainment
PENN
$2.82B
| $509K | ﹤0.01% |
6,665
+257
| +4% | +$22.1K |
|
1548
Pennant Group
PNTG
$1.46B
| $507K | ﹤0.01% |
12,407
+3,145
| +34% | +$122K |
|
1549
Glaukos
GKOS
$8.89B
| $506K | ﹤0.01% |
5,969
+5,432
| +1,012% | +$446K |
|
1550
Boston Beer
SAM
$1.93B
| $504K | ﹤0.01% |
494
+23
| +5% | +$25.8K |
|
Similar funds
US Bancorp's Q2 2021 Portfolio in Review
As of Q2 2021, US Bancorp held 4,164 positions worth $53.4B, up 8% from $49.4B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
US Bancorp's Q2 2021 filing shows 242 new, 1,490 increased, 1,373 reduced and 118 closed positions. Its largest new stake was Organon & Co: 165,056 shares worth $5M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $28M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- US Bancorp's largest Q2 2021 buy was Organon & Co: 165,056 shares worth $5M.
- US Bancorp added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $110M increase.
- US Bancorp's biggest Q2 2021 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $28M.
- US Bancorp fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $6.31M.
- US Bancorp's ten largest holdings make up 28% of its $53.4B portfolio in Q2 2021.
- US Bancorp opened 242 new positions and closed 118 in Q2 2021.
- US Bancorp's portfolio value rose 8% quarter-over-quarter to $53.4B.
Based on US Bancorp's 13F filing for Q2 2021, filed 5 Aug 2021.